Workshop Date and Time

Tuesday, May 16, 2017, 1:30 – 2:30 pm, Eastern Time Register Now

Registrants can listen in live over the phone or online as a webcast.

Our Panel of Experts

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Attending Physician, Leukemia Service, Member, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Neil P. Shah, MD, PhD

Edward S. Ageno Distinguished Professor in Hematology/Oncology, Director, UCSF Molecular Medicine Residency Program, Leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Elias Jabbour, MD

Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Carolyn Messner, DSW, OSW-C, FAPOS

Director of Education and Training, CancerCare

Continuing Education Credits

This program has been submitted for 1.0 Contact Hour to social workers by The University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607. This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).

For New York State Licensed Social Workers: Cancer Care Inc. SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0088. This workshop is approved for 1.0 Contact Hour for the live program only.

To receive the continuing education paperwork, please email connect@cancercare.org with your name, title and address. All paperwork for continuing education credit must be submitted within two weeks of the live program.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top